The global advanced wound care market is estimated to grow at a CAGR of 7.0% from 2015 to 2020. North America holds the largest share in the global advanced wound care market, and the region鈥檚 market is expected to grow at a CAGR of 6.9% during the forecast period.
In this report, the global advanced wound care market has been broadly classified on the basis of application, type, geography and end user. The application segment is divided into surgical wounds, ulcers, and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers and arterial ulcers. The type segmentation includes dressings and grafts, where dressings are further categorized into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, and alginate dressings; grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts include autografts, allografts, and xenografts. The geographic analysis includes regions, such as North America, Europe, Asia-Pacific, and the rest of the world (RoW). The end-user includes in-patient facilities and out-patient facilities.
Active wound care is the fastest growing segment which is estimated to grow at the highest CAGR from 2015 to 2020. Factors such as rising incidences of chronic wounds due to aging population, increasing incidences of diabetes, and lifestyle factors are driving the growth of this market. The rapidly increasing aging population across the world is a major driver for the growth of the global advanced wound care market. According to the WHO, between 2000 and 2050, the percentage of the global population of individuals aged above 60 years will witness a twofold increase鈥攆rom about 11% to 22%.
The major companies in this market include Acelity L.P., Inc. (U.S.), Smith and Nephew Plc. (U.K.), Integra Lifesciences Corporation (U.S.), M枚lnlycke Health Care (Sweden), ConvaTec, Inc. (U.S.), Coloplast Corp. (Denmark), Organogenesis Inc. (U.S.), Medline Industries, Inc. (U.S.), and MPM Medical, Inc. (RBC Life Sciences, Inc.) (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the global anesthesia monitoring devices market.
